Basic Information
| RNALocate ID: | RLID-D:11001243 |
| RNA Symbol: | hsa-miR-491-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-491-5p |
| RNA ID: | miRBase:MIMAT0002807 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002320 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002321 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002322 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002955 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11002956 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11002957 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000476 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-491-5p | Medulloblastoma | MNDR-E-MI-54235 |
| MNDR | hsa-miR-491-5p | Neurofibromatosis 1 | MNDR-E-MI-54236 |
| MNDR | hsa-miR-491-5p | Dermatomyositis | MNDR-E-MI-54237 |
| MNDR | hsa-miR-491-5p | Prostate cancer | MNDR-E-MI-54238 |
| MNDR | hsa-miR-491-5p | Gastric cancer | MNDR-E-MI-54239 |
| MNDR | hsa-miR-491-5p | Alzheimer disease | MNDR-E-MI-54240 |
| MNDR | hsa-miR-491-5p | Esophageal carcinoma | MNDR-E-MI-54241 |
| MNDR | hsa-miR-491-5p | Dysautonomia familial | MNDR-E-MI-54242 |
| MNDR | hsa-miR-491-5p | Head and neck cancer | MNDR-E-MI-54243 |
| MNDR | hsa-miR-491-5p | Lung cancer | MNDR-E-MI-54244 |
| MNDR | hsa-miR-491-5p | Parkinson disease | MNDR-E-MI-54245 |
| MNDR | hsa-miR-491-5p | Pituitary neoplasms | MNDR-E-MI-54246 |
| MNDR | hsa-miR-491-5p | Pancreatic cancer | MNDR-E-MI-54247 |
| MNDR | hsa-miR-491-5p | Melanoma | MNDR-E-MI-54248 |
| MNDR | hsa-miR-491-5p | Rectum adenocarcinoma | MNDR-E-MI-54249 |
| MNDR | hsa-miR-491-5p | Colon cancer | MNDR-E-MI-54250 |
| MNDR | hsa-miR-491-5p | Ischemic attack transient | MNDR-E-MI-54251 |
| MNDR | hsa-miR-491-5p | Colon adenocarcinoma | MNDR-E-MI-54252 |
| MNDR | hsa-miR-491-5p | Multiple sclerosis | MNDR-E-MI-54253 |
| MNDR | hsa-miR-491-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-54254 |
| MNDR | hsa-miR-491-5p | Familial ovarian cancer | MNDR-E-MI-54255 |
| MNDR | hsa-miR-491-5p | Prostate adenocarcinoma | MNDR-E-MI-54256 |
| MNDR | hsa-miR-491-5p | Carcinoma ductal breast | MNDR-E-MI-54257 |
| MNDR | hsa-miR-491-5p | Glioblastoma | MNDR-E-MI-54258 |
| MNDR | hsa-miR-491-5p | Glioma | MNDR-E-MI-54259 |
| MNDR | hsa-miR-491-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-54260 |
| MNDR | hsa-miR-491-5p | Osteosarcoma | MNDR-E-MI-54261 |
| MNDR | hsa-miR-491-5p | Inclusion body myositis | MNDR-E-MI-54262 |
| MNDR | hsa-miR-491-5p | Liver cancer | MNDR-E-MI-54263 |
| MNDR | hsa-miR-491-5p | Gastric adenocarcinoma | MNDR-E-MI-54264 |
| MNDR | hsa-miR-491-5p | Pituitary adenoma | MNDR-E-MI-54265 |
| MNDR | hsa-miR-491-5p | Lung squamous cell carcinoma | MNDR-E-MI-54266 |
| MNDR | hsa-miR-491-5p | Carcinoma lung non-small-cell | MNDR-E-MI-54267 |
| MNDR | hsa-miR-491-5p | Lung adenocarcinoma | MNDR-E-MI-54268 |
| MNDR | hsa-miR-491-5p | Cervical cancer | MNDR-E-MI-54269 |
| MNDR | hsa-miR-491-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54270 |
| MNDR | hsa-miR-491-5p | Cholangiocarcinoma | MNDR-E-MI-54271 |
| MNDR | hsa-miR-491-5p | Prolactinoma | MNDR-E-MI-54272 |
| MNDR | hsa-miR-491-5p | Lung small cell carcinoma | MNDR-E-MI-54273 |
| MNDR | hsa-miR-491-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-54274 |
| MNDR | hsa-miR-491-5p | Adenoma | MNDR-E-MI-54275 |
| MNDR | hsa-miR-491-5p | Breast invasive carcinoma | MNDR-E-MI-54276 |
| MNDR | hsa-miR-491-5p | Hepatocellular carcinoma | MNDR-E-MI-54277 |
| MNDR | hsa-miR-491-5p | Familiar ovarian carcinoma | MNDR-E-MI-54278 |
| MNDR | hsa-miR-491-5p | Acute myelocytic leukemia | MNDR-E-MI-54279 |
| MNDR | hsa-miR-491-5p | Colorectal cancer | MNDR-E-MI-54280 |
| MNDR | hsa-miR-491-5p | Nasopharyngeal carcinoma | MNDR-E-MI-54281 |
| MNDR | hsa-miR-491-5p | Nasopharynx carcinoma | MNDR-E-MI-54282 |
| MNDR | hsa-miR-491-5p | Uterine cervical neoplasms | MNDR-E-MI-54283 |
| MNDR | hsa-miR-491-5p | Nasopharyngeal cancer | MNDR-E-MI-54284 |
| MNDR | hsa-miR-491-5p | Stroke lacunar | MNDR-E-MI-54285 |
| MNDR | hsa-miR-491-5p | HPV | MNDR-E-MI-54286 |
| MNDR | hsa-miR-491-5p | Multiple sclerosis susceptibility | MNDR-E-MI-54287 |
| MNDR | hsa-miR-491-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-54288 |
| MNDR | hsa-miR-491-5p | Tubulovillous adenoma | MNDR-E-MI-54289 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2L1 | Homo sapiens | RR00219219 |
TOP